•
Jun 30, 2021

Voyager Therapeutics Q2 2021 Earnings Report

Total Revenue
$1.36M
Previous year: $28.7M
-95.3%
EPS
-$0.8
Previous year: -$0.23
+247.8%
Gross Profit
-$18.1M
Previous year: -$742K
+2345.8%
Cash and Equivalents
$118M
Previous year: $144M
-18.3%
Free Cash Flow
-$22.9M
Previous year: -$23.1M
-0.6%
Total Assets
$209M
Previous year: $297M
-29.8%

Voyager Therapeutics

Voyager Therapeutics

Voyager Therapeutics Revenue by Segment